Celgene
1986
FOUNDED
M&A
STATUS
5K-10K
EMPLOYEES
M&A
LATEST DEAL TYPE
$74B
LATEST DEAL AMOUNT
Description
Celgene is a biopharmaceutical firm that discovers, develops, and markets therapeutics for the treatment of cancer and immunological diseases. Celgene markets Thalomid and Pomalyst to treat multiple myeloma and Revlimid, a less toxic thalidomide derivative, to treat myelodysplastic syndromes, multiple myeloma, and mantle cell lymphoma. Acquisitions have brought MDS drug Vidaza, T-cell lymphoma drug Istodax, and cancer drug Abraxane. The firm's first immunology drug, Otezla, was approved in the U.S. in 2014. Recent acquisitions of Juno and Impact bring additional drugs for Celgene's blood cancer pipeline.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Office
- 86 Morris Avenue
- Summit, NJ 07901
- United States
+1 (908) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Celgene’s full profile, request a free trial.
Celgene Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 20-Nov-2019 | $74B | 000.00 | 0000 | Completed | Profitable |
| 3. PIPE | 000.00 | Completed | Profitable | |||
| 2. IPO | 28-Jul-1987 | $12.7M | $12.7M | Completed | Generating Revenue | |
| 1. Early Stage VC | 01-Jan-1986 | Completed | Generating Revenue |
Celgene Competitors (22)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals | Formerly VC-backed | Tarrytown, NY | 0000 | 00000 | 000000000 00 | 00000 |
| 000000000 | Formerly VC-backed | Exton, PA | 000 | 0000 | 000000&0 | 0000 |
| 000000 | Formerly VC-backed | Cambridge, MA | 0000 | 000.00 | 00000000000 | 000.00 |
| 00000 000000000 | Formerly VC-backed | Boulder, CO | 000 | 00000 | 000000&0 | 00000 |
| 00000 & 00. | Corporation | Kenilworth, NJ | 00000 |
Celgene Investments & Acquisitions (125)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 | 20-Dec-2019 | 00000 00000 00 | 000.00 | Therapeutic Devices | |
| 000000 00000000000 | 15-Oct-2019 | 00000 00000 00 | 000.00 | Biotechnology | 00000 000000000 |
| 0000000 | 11-Sep-2019 | 00000 00000 00 | 0000 | Drug Discovery | |
| 0000 000000000000 | 18-Jun-2019 | 00000 00000 00 | 0000 | Drug Discovery | |
| Cleave Therapeutics | 17-Jun-2019 | Later Stage VC | 0000 | Pharmaceuticals |
Celgene Exits (41)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000 000000000000 | 18-Jun-2019 | 00000 00000 00 | 0000 | Completed |
|
| 00000 000000000 | 26-Jul-2018 | 00000 00000 00 | 000.00 | Completed |
|
| 0000 000000000000 | 01-Apr-2018 | 00000 00000 00 | 0000 | Completed |
|
| 00000 00000000000 | 23-Mar-2018 | 00000 00000 00 | 000.00 | Completed |
|
| Arcus Biosciences | 03-Nov-2017 | Later Stage VC | 00000 | Completed |
|
Celgene Subsidiaries (5)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| EngMab | Biotechnology | Pfaffikon, Switzerland | 2013 |
| 000000000 00000000 | Therapeutic Devices | San Francisco, CA | 0000 |
| 00000000 000000000 | Drug Discovery | Boston, MA | 0000 |
| 00000 000000000000 | Biotechnology | Watertown, MA | 0000 |
| 0000000000000 | Diagnostic Equipment | Rockville, MD | 0000 |
Celgene Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Asseily Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| BB Biotech | Asset Manager | Minority | 000 0000 | 000000 0 | ||
| CHL Medical Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Edelson Technology Partners | Venture Capital | Minority | 000 0000 | 000000 0 |
Celgene Executive Team (62)
43 Former Executives
You’re viewing 5 of 62 executives. Get the full list »Celgene Board Members (28)
14 Former Board Members
You’re viewing 5 of 28 board members. Get the full list »